Past events with contributions from the working group

Published

December 20, 2024

Below a list of past events with contributions of the WG, with links to slidedecks and recordings (where available).

01.10.2024: 2024 DSFE Annual Conference

Contribution of the working group: Poster (encore)

Nyborg / Denmark

Speaker Institution Title Download slides
Lotte Husemoen Novo Nordisk (ENCORE) The ICH E9(R1) Estimands Framework in the context of Real-World Data and Observational Studies No presentation available

11.09.2024: 2024 EFSPI regulatory statistics workshop

Contribution of the working group: Poster

Biozentrum Basel / Switzerland

Speaker Institution Title Download slides
Stefan Englert J&J An Appraisal of the ICH E9(R1) Intercurrent Event Definition with Case Examples link
Sue McKendrick PPD Clinical Research Services Considerations when Selecting Strategies for Intercurrent Events in Non-inferiority Trials link
Vivian Lanius Bayer AG Realizing the benefits of estimands when reporting and communicating study results – some recommendations link

24.08.2024: 2024 ISPE Annual Conference

Contribution of the working group: Poster

Berlin / Germany

Speaker Institution Title Download slides
Lotte Husemoen Novo Nordisk (ENCORE) The ICH E9(R1) Estimands Framework in the context of Real-World Data and Observational Studies No presentation available

17.06.2024: 2024 PSI Annual Conference - Panel

Contribution of the working group: Panel discussion

Amsterdam / Netherlands

Speaker Institution Title Download slides
Kit Roes Chair EMA MWP Estimands in non-inferiority trials: challenges in implementation panel discussion - Panelist 1 No presentation available
David Wright AstraZeneca Estimands in non-inferiority trials: challenges in implementation panel discussion - Panelist 2 No presentation available
Tobias Mütze Novartis Estimands in non-inferiority trials: challenges in implementation panel discussion - Panelist 3 No presentation available
Helle Lynggaard Novo Nordisk Estimands in non-inferiority trials: challenges in implementation panel discussion - Panelist 4 No presentation available
Florian Lasch EMA Estimands in non-inferiority trials: challenges in implementation panel discussion - Panelist 5 No presentation available
Khadija Rantell MHRA Estimands in non-inferiority trials: challenges in implementation panel discussion - Panelist 6 No presentation available

16.06.2024: 2024 PSI Annual Conference - Talks

Contribution of the working group: Oral presentation

Amsterdam / Netherlands

Speaker Institution Title Download slides
Helle Lynggaard Novo Nordisk Non-inferiority and the estimand framework link
David Wright AstraZeneca How the estimand framework affects choice of non-inferiority margin link

12.06.2024: 2024 NordicEpi Annual Conference

Contribution of the working group: Talk

Copenhagen / Denmark

Speaker Institution Title Download slides
Lotte Husemoen Novo Nordisk The ICH E9(R1) Estimands Framework in the context of Real-World Data and Observational Studies No presentation available

14.11.2023: 2023 ISPOR Annual European conference

Contribution of the working group: Poster

Copenhagen / Denmark

Speaker Institution Title Download slides
Pepa Polavieja/Antonia Morga Novo Nordisk/Astellas Estimands in Health Technology Assessments: methodological considerations and recommendations No presentation available

13.09.2023: 8th EFSPI Workshop on Regulatory Statistics 2023

Contribution of the working group: Poster

Basel / Switzerland

Speaker Institution Title Download slides
Stefan Englert J&J How the Estimand Implementation Working Group brings together statisticians and clinicians to support the estimand journey link

11.06.2023: 2023 PSI Annual Conference

Contribution of the working group: Oral presentation

London / United Kingdom

Speaker Institution Title Download slides
Sunita Rehal GSK The estimands framework in non-inferiority trials:​ Past, Present & Future​ link
Pepa Polavieja/Antonia Morga Novo Nordisk/Astellas The ICH E9(R1) Addendum in the context of Health Technology Assessments: methodological considerations and recommendations - Speaker 3 No presentation available
Paul Terrill Ptstat.co.uk UPDATE - Estimand Implementation Working Group (EIWG) link
Helle Lynggaard Novo Nordisk Does it Make Sense to Apply the Estimand Framework to Clinical Pharmacology Trials? - Speaker 1 link
Sue McKendrick PPD Clinical Research Services Does it Make Sense to Apply the Estimand Framework to Clinical Pharmacology Trials? - Speaker 2 link

01.11.2022: EFSPI Newsletter

Contribution of the working group: Article

Online / Online

Speaker Institution Title Download slides
EIWG EIWG brings together statisticians and clinicians to support the estimand journey link

12.06.2022: 2022 PSI Annual Conference

Contribution of the working group: Poster

Gothenburg / Sweden

Webpage of the event

Speaker Institution Title Download slides
Stefan Englert J&J UPDATE - Estimand Implementation Working Group (EIWG) link
Helle Lynggaard Novo Nordisk Does the Estimand Framework Add Value to Clinical Pharmacology Trials? link

21.06.2021: 2021 PSI Annual Conference

Contribution of the working group: Oral presentation

Online / Online

Speaker Institution Title Download slides
Pepa Polavieja Lilly ICH E9(R1) Implementation in Study Protocols - Speaker 1 link
Helle Lynggaard Novo Nordisk ICH E9(R1) Implementation in Study Protocols - Speaker 2 link